These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18004141)

  • 21. Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone.
    Nelson MW; Reynolds RR; Kelly DL; Conley RR
    Clin Neuropharmacol; 2003; 26(6):297-8. PubMed ID: 14646608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of aging on the improvement of subjective sleep quality by atypical antipsychotic drugs in patients with schizophrenia: comparison of middle-aged and older adults.
    Yamashita H; Mori K; Nagao M; Okamoto Y; Morinobu S; Yamawaki S
    Am J Geriatr Psychiatry; 2005 May; 13(5):377-84. PubMed ID: 15879586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risperidone and clozapine for treatment-resistant schizophrenia.
    Dunayevich E; Chatterjee A
    Am J Psychiatry; 1999 Jul; 156(7):1127; author reply 1127-8. PubMed ID: 10401486
    [No Abstract]   [Full Text] [Related]  

  • 24. The CATIE schizophrenia effectiveness trial.
    Delisi LE; Nasrallah HA
    Schizophr Res; 2005 Dec; 80(1):v-vi. PubMed ID: 16291292
    [No Abstract]   [Full Text] [Related]  

  • 25. A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.
    Potkin SG; Gharabawi GM; Greenspan AJ; Mahmoud R; Kosik-Gonzalez C; Rupnow MF; Bossie CA; Davidson M; Burtea V; Zhu Y; Trivedi JK
    Schizophr Res; 2006 Jul; 85(1-3):254-65. PubMed ID: 16797162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
    Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cataracts and quetiapine.
    Valibhai F; Phan NB; Still DJ; True J
    Am J Psychiatry; 2001 Jun; 158(6):966. PubMed ID: 11384916
    [No Abstract]   [Full Text] [Related]  

  • 28. Antipsychotic drugs and schizophrenia.
    Essock SM; Covell NH; Jackson CT
    N Engl J Med; 2006 Jan; 354(3):298-300; author reply 298-300. PubMed ID: 16422020
    [No Abstract]   [Full Text] [Related]  

  • 29. Cost of antipsychotic polypharmacy in the treatment of schizophrenia.
    Zhu B; Ascher-Svanum H; Faries DE; Correll CU; Kane JM
    BMC Psychiatry; 2008 Apr; 8():19. PubMed ID: 18394168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended-release quetiapine fumarate (quetiapine XR) versus risperidone in the treatment of depressive symptoms in patients with schizoaffective disorder or schizophrenia: a randomized, open-label, parallel-group, flexible-dose study.
    Di Fiorino M; Montagnani G; Trespi G; Kasper S
    Int Clin Psychopharmacol; 2014 May; 29(3):166-76. PubMed ID: 24681810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative pilot study of second-generation antipsychotics in children and adolescents with schizophrenia-spectrum disorders.
    Jensen JB; Kumra S; Leitten W; Oberstar J; Anjum A; White T; Wozniak J; Lee SS; Schulz SC
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):317-26. PubMed ID: 18759641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial.
    Lublin H; Haug HJ; Koponen H; Sigmundsson T; Kolb SA
    World J Biol Psychiatry; 2009; 10(4 Pt 3):710-8. PubMed ID: 18803070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sleep-promoting properties of quetiapine in healthy subjects.
    Cohrs S; Rodenbeck A; Guan Z; Pohlmann K; Jordan W; Meier A; Rüther E
    Psychopharmacology (Berl); 2004 Jul; 174(3):421-9. PubMed ID: 15029469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms.
    Riedel M; Müller N; Strassnig M; Spellmann I; Engel RR; Musil R; Dehning S; Douhet A; Schwarz MJ; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):432-7. PubMed ID: 16267634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy.
    Kapur S; Zipursky R; Jones C; Shammi CS; Remington G; Seeman P
    Arch Gen Psychiatry; 2000 Jun; 57(6):553-9. PubMed ID: 10839333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current pharmacotherapy of schizophrenia].
    Bitter I
    Orv Hetil; 2004 Jan; 145(3):105-9. PubMed ID: 15027331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine.
    Kelly DL; Conley RR
    J Clin Psychiatry; 2005 Jan; 66(1):80-4. PubMed ID: 15669892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study.
    Voruganti L; Cortese L; Owyeumi L; Kotteda V; Cernovsky Z; Zirul S; Awad A
    Schizophr Res; 2002 Oct; 57(2-3):201-8. PubMed ID: 12223251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia.
    Lambert BL; Cunningham FE; Miller DR; Dalack GW; Hur K
    Am J Epidemiol; 2006 Oct; 164(7):672-81. PubMed ID: 16943266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.